Pharmacogenomics in Epithelial Ovarian Cancer First-Line Treatment Outcome: Validation of Gwas-Associated Nrg3 Rs1649942 and Bre Rs7572644 Variants in an Independent Cohort
AuthID
P-00P-QSK
P-00P-QSK